Movement Alert|Pfizer Rises 3.08% in Regular Trading, Pharma Sector Broadly Lifted by GlaxoSmithKline Strong Q2 Earnings

Market Focus
07/28

On July 28, Pfizer rose 3.08% in regular trading, trading at $25.375/share, with turnover of $369 million. The rally was driven by a broad pharma sector uplift following GlaxoSmithKline's better-than-expected second-quarter earnings report.

GlaxoSmithKline reported adjusted earnings per share of 50.5 pence, significantly exceeding the market consensus estimate of 46.8 pence. The company also announced plans to fully achieve annual cost savings of GBP 1.9 billion by 2029, further boosting investor confidence in sector-wide profitability. The strong results triggered a rally across major pharmaceutical names, with GlaxoSmithKline up 5.62%, Merck up 2.82%, Eli Lilly up 2.53%, Johnson & Johnson up 2.45%, and AstraZeneca up 2.15%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10